Objectives: To estimate costs of pharmacotherapy of recurrent depressive disorder (RDD) in a hospital-based care.
Methods: In the study, we analyzed the real-world practice in hospital-based care and the costs of RDD pharmacotherapy. A total of 119 case histories of patients who received a diagnosis of RDD and were hospitalized in 2017 were retrospectively analyzed.